11 Most Undervalued Growth Stocks to Buy According to Hedge Funds

Page 9 of 10

​2. Pfizer Inc. (NYSE:PFE)

Forward P/E Ratio: 7.78

Number of Hedge Fund Holders: 83

​Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer Inc. (NYSE:PFE) with a price target of $30.

​The analyst pointed to the company’s recent acquisition of Metsera. He noted that the deal allows Pfizer Inc. (NYSE:PFE) to re-enter the obesity treatment market and brings promising long-acting GLP-1 and amylin agents. These drugs could compete well against current leaders like Lilly and Novo.

​Moreover, the acquisition includes contingent value rights. This structure reduces the company’s risk while enhancing its market position. Seigerman also likes the valuation of Pfizer Inc. (NYSE:PFE) compared to other companies in the sector. He sees potential for the company to grow revenue and improve margins. These growth prospects are not yet fully recognized by the market.

​Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company focused on discovering, developing, manufacturing, and marketing medicines.

Page 9 of 10